Table 4.
ECHO parameters | Placebo (n=25) |
GSH (n=25) |
P value |
Baseline | |||
LVEDV (mL/m2) | 121.3±17.2 | 124.4±22.3 | 0.44 |
LVESV (mL/m2) | 65.4±11.3 | 66.3±13.2 | 0.91 |
LVEF (%) | 47.5±4.9 | 46.9±4.8 | 0.42 |
Follow-up | |||
LVEDV (mL/m2) | 118.1±17.8 | 113.2±14.1 | 0.42 |
LVESV (mL/m2) | 60.9±10.7 | 58.8±12.5 | 0.91 |
LVEF (%) | 49.1±3.2 | 49.8±3.7 | 0.42 |
GSH, glutathione; LVESV, left ventricular end-systolic volume; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction.